Dowie, M J <br/><br/>
Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease.  [electronic resource] 

 -  Neuroscience  Sep 2009 
 - 456-65 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-7544 
<br/><br/><label>Standard No.: </label>10.1016/j.neuroscience.2009.06.014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Arachidonic Acids--metabolism<br/>Binding, Competitive--drug effects<br/>Brain--metabolism<br/>Cannabinoid Receptor Modulators--metabolism<br/>Cannabinoids--pharmacology<br/>Corpus Striatum--metabolism<br/>Disease Models, Animal<br/>Down-Regulation--physiology<br/>Dyskinesias--etiology<br/>Endocannabinoids<br/>Glycerides--metabolism<br/>Hippocampus--metabolism<br/>Huntington Disease--metabolism<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Inbred CBA<br/>Mice, Transgenic<br/>Polyunsaturated Alkamides--metabolism<br/>RNA, Messenger--metabolism<br/>Receptor, Cannabinoid, CB1--drug effects<br/>Receptors, Dopamine--drug effects<br/>Substantia Nigra--metabolism